Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Endocrinology|February 2, 2012
Preclinical characterization of a novel diphenyl benzamide selective ERα agonist for hormone therapy in prostate cancerChristopher C Coss, Amanda Jones, Deanna N Parke, et al.
Plos One|January 4, 2014
Discovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammationRamesh Narayanan, Muralimohan Yepuru, Christopher C Coss, et al.
Scientific Reports|February 12, 2021
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networksTimothy H Helms, Riley D Mullins, Jennifer M Thomas-Ahner, et al.
Molecular Pharmaceutics|May 8, 2023
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo ModelsElizabeth N Kaweesa, Jaqueline M Bazioli, Herma C Pierre, et al.
Molecular & Cellular Proteomics : MCP|March 25, 2026
Natural product target identification of wheldone, a fungal metabolite, as a KIF11 inhibitor in ovarian cancer using the DiffPOP (Differential Protein Precipitation) methodManead Khin, Alejandra Cavazos Saldana, Manuel Rangel-Grimaldo, et al.
The AAPS Journal|March 5, 2016
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in RodentsHao Cheng, Zhiliang Xie, William P Jones, et al.
Scientific Reports|November 3, 2025
OSU-ERβ-12: a promising pre-clinical candidate selective estrogen receptor beta agonistGregory M Young, Timothy H Helms, Samuel K Kulp, et al.
Journal of Medicinal Chemistry|June 28, 2021
Structure-Activity Relationship of <i>para</i>-Carborane Selective Estrogen Receptor β AgonistsDavid Sedlák, Tyler A Wilson, Werner Tjarks, et al.
Cancer Research Communications|March 10, 2025
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia SusceptibilityHanieh Taheri, Yang Li, Kevin M Huang, et al.
European Urology|June 28, 2014
Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancerEvan Y Yu, Robert H Getzenberg, Christopher C Coss, et al.
Pageof 7